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Abstract
Aim: This research aimed to evaluate the effects of pomegranate extract standardized to 40% ellagic acid on the incised 
wound in albino rats.
Materials and Methods: Fifty albino rats were divided into 10 treatment groups. The five groups were sacrificed on the 
8th day, while the others were sacrificed on the 15th day. Two groups of albino rats with incised wound were not treated at all 
(P0), the other two groups of albino rats with incised wound were treated with Betadine® (P1) ointment, and the rest of the 
groups were treated with pomegranate extract standardized to 40% ellagic acid with a concentration of 2.5% (P2), 5% (P3), and 
7.5% (P4). The treatments were carried out twice a day with an interval of 12 h for 7 and 14 days. At the end of the research, 
the skin tissue of those albino rats had been taken for histopathologic preparations before H and E staining was performed.
Results: Collagen deposition,  polymorphonuclear neutrophils (PMN) infiltration, angiogenesis, and fibrosis degree in 
Group P4 treated with 7.5% pomegranate extract standardized to 40% ellagic acid for 14 days were significantly different 
from those in Groups P0, P1, P2, and P3, especially in the case of PMN inflammation (p<0.05).
Conclusion: The administration of 7.5% pomegranate extract standardized to 40% ellagic acid for 14 days on incised 
wounds of those albino rats can accelerate the wound healing process characterized by collagen deposition improvement, 
PMN infiltration in the wound area, angiogenesis, and fibrosis degree.
Keywords: albino rats, ellagic acid, incision wound, pomegranate, wound healing process.
Introduction
Wound healing process is a complex phenome-
non to restore the continuity of tissues and their func-
tion. Wound healing process involves several distinct 
and overlapping phases, namely, inflammatory phase, 
granulation phase, fibrogenesis phase, neovascular-
ization phase, wound contraction phase, and epithe-
lialization phase [1]. Effective wound management, 
as a result, requires an understanding of the normal 
wound healing process as well as is expected to be 
able to choose the right interventions to optimize the 
wound healing process [2].
Inflammation, moreover, occurs immediately 
after the injury, started with vasoconstriction that plays 
a role in triggering hemostasis process and releas-
ing inflammatory mediators. Next, the proliferative 
phase is characterized by the formation of granula-
tion tissue by fibroblasts and angiogenesis processes. 
Reformulation and repair of collagen fiber compart-
ments accompanied by increased tensile strength then 
indicate remodeling phase [3]. However, there are 
several factors inhibiting wound healing process, such 
as recurrent trauma, poor perfusion, and oxygenation, 
as well as excessive inflammation [4].
Therefore, natural ingredients are considered as 
an essential part of health management and a good 
method for providing a cheap and effective health-
care option, especially for wound treatment [5,6]. 
For instance, Punica granatum Linn. (Punicaceae), 
commonly called as pomegranate, a shrub from the 
Mediterranean [7,8], has been proven by several pre-
vious researches as good medicine for wound healing 
process [5,6,8]. Pomegranate fruit and flowers even 
have been widely used by the public for treating gastri-
tis, gastrointestinal infections, gastrointestinal bleed-
ing, dysentery, and various types of wounds [8,9].
Pomegranate, furthermore, has been known to 
have antitumor, antidiarrheal, antiulcer, antifungal, 
antioxidant, and hepatoprotector activities [7,10]. 
Pomegranate extract is also widely used for the treatment 
of diabetes mellitus and bacterial infection [11,12]. Some 
previous researchers even have proven that pomegran-
ate extract contains polyphenol compounds, namely, 
ellagic acid, 3.3’, 4’ -tri-O-methyl ellagic acid, ethyl 
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brevifolin carboxylate, maslinic acid, daucosterol, 
and tannin [13,14]. Ellagic acid has antioxidant and 
anti-inflammatory activity through free radical scav-
enging, regulation of phase 1 and 1 enzymes, modu-
lates the secretion of proinflammatory and profibrotic 
cytokines and regulates the biochemical pathways that 
involved in lipid synthesis and degradation during 
inflammation [15]. Previous studies have been reported 
the compounds that responsible for antioxidant, anti-in-
flammatory, and antibacterial activities. Tannins, which 
consisted of punicallin, punicalagin, pedunculagin, gal-
lic acid, and casuarinin are responsible as antioxidant. 
The ellagic acid, gallic acid, punicalagin, granatin, 
and gallagyldilactone are compounds that have anti-in-
flammatory effect. Catechin, epicatechin, epigalloca-
thecin-3-gallate, flavan-3-ol, kaempferol, and querce-
tin are compounds that have antibacterial activity and 
have reported also as an antioxidant, anti-inflammatory, 
antiviral and anti-neoplastic [16-18]. Unfortunately, 
there was still a lack of researchers on the potency of 
pomegranate extract standardized to 40% ellagic acid 
for wound healing. Thus, this research aimed to reveal 
the effects of pomegranate extract standardized to 40% 
ellagic acid as a regulator of incised wound healing pro-
cess in albino rats as experimental animals.
Materials and Methods
Ethical approval
This research has been approved by the eth-
ical commission of Faculty of Dental Medicine, 
Universitas Airlangga, with Ethical Clearance 
Certificate’s Number 108/HRECC.FODM/VII/2017.
Experimental animals
In this research, 50 healthy male albino rats 
(Rattus norvegicus) aged 3 months old and weighed 
150-180 g were used as experimental animals.
Research materials
Materials used in this research were whole fruit 
extract of pomegranate (P. granatum Linn.) stan-
dardized with 40% ellagic acid produced by Xi’an 
Bio-Technology Co., Ltd., Betadine® (PT One Med), 
Ketamin® (PT Guardian Pharmatama), diazepam, 
vaseline flavum, 70% ethanol, 10% formalin buffer, 
alcohol at various concentrations, pellet, and sterile 
aquadest. This research also used some materials for 
making preparations of histopathological examination 
using hematoxylin-eosin (HE) staining technique.
Research tools
Research tools used were some surgical tools 
for making incised wounds and removing skin tis-
sue, such as gloves, scissors, sterile cotton, plastic 
spoon, cotton bud, tweezers, clamp arteries, scalpel 
number 3, ruler, Hypafix, blade number 10, and razor 
blade. This research also used pots to place the skins 
that had been excised.
Besides, mortar and stamper were used in this 
research for making ointments. Some tools for making 
histopathology preparations, such as microtome and 
embedding set, glass object, glass cover, staining set, 
as well as microscope were also used.
Treatment
Fifty male albino rats (R. norvegicus) were 
adapted first for 1 week. During the adaptation period, 
they were fed with sufficient food and drink. They 
also got several health examinations and treatments.
After the adaptation period, rats then were 
randomly divided into 10 treatment groups with five 
different treatments. Variables then observed were 
histopathologic images of those albino rats’ incised 
skin (R. norvegicus).
The use of pure ellagic acid (100%) for topical 
administration on infected wounds that infected with 
Staphylococcus aureus showed that 1% concentra-
tion gave the best results in accelerating the process 
of wound healing [19]. Based on that research, the 
topical ointment preparations, 2.5, 5, and 7.5% of 
pomegranate extract that standardized 40% of ellagic 
acid were used in this study (ellagic acid content in 
each dosage is 1, 2, and 3%).
Treatments administrated in this research were 
as follows:
P0.1: Incised wounds without any treatment and 
observed on day 8
P0.2: Incised wounds without any treatment and 
observed on day 15
P1.1: Incised wounds treated with Betadine® and 
observed on day 8
P1.2: Incised wounds treated with Betadine® and 
observed on day 15
P2.1: Incised wounds treated with 2.5% pomegranate 
extract ointment standardized to 40% ellagic acid 
and then observed on day 8
P2.2: Incised wounds treated with 2.5% pomegranate 
extract ointment standardized to 40% ellagic acid 
and then observed on day 15
P3.1: Incised wounds treated with 5% pomegranate 
extract ointment standardized to 40% ellagic acid 
and then observed on day 8
P3.2: Incised wounds treated with 5% pomegranate 
extract ointment standardized to 40% ellagic acid 
and then observed on day 15
P4.1: Incised wounds treated with 7.5% pomegranate 
extract ointment standardized to 40% ellagic acid 
and then observed on day 8
P4.2: Incised wounds treated with 7.5% pomegranate 
extract ointment standardized to 40% ellagic acid 
and then observed on day 15
In all groups, except for Group P0.1 and P0.2, 
those rats were shaved off in their paravertebral area 
of 3 cm×2.5 cm to facilitate the incision process. At 
the time of making the wound, those rats were anes-
thetized in advance with a combination of ketamine 
and diazepam (100 mg/ml: 5 mg/ml) at a dose of 1 ml/
kg of body weight [20]. The incision then was car-
ried straight toward the caudals along 3 cm, 0.25 cm 
deep, and 0.01 cm wide in the area that had been 
shaved [21].
Next, certain treatments were given topically by 
applying Betadine® ointment for certain groups, and 
pomegranate extract ointment standardized to 40% 
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ellagic acid for some other groups with a cotton bud. 
Those treatments were performed twice in a day with 
an interval of 12 h for 7 and 14 days [22].
Afterward, skin tissue and blood of those albino 
rats were taken after they were sacrificed using ether 
per inhalation. The skin tissue was taken with a scal-
pel at a depth of 0.5 cm and over 1 cm from the right, 
left, top, and bottom sides of the incised wound to 
make histopathologic preparations.
Observation
The histologic criteria for skin preparation were 
defined as follows:
1. Collagen was indicated with score 2 for a nor-
mal bundle of collagen, score 1 for unorganized/
edema of collagen, and score 0 for amorphous one
2. Polymorphonuclear neutrophils (PMN) was indi-
cated with score 2 for a PMN cell count of 0-10, 
score 1 for a PMN cell count of 11-40, and score 
0 for a PMN cell count of >40
3. Angiogenesis was categorized into three degrees, 
namely, mild, moderate, and severe
4. Fibrosis degree was indicated by measuring the 
thickness of collagen bundles, divided into three, 
namely, mild, moderate, and severe [23].
Statistical analysis
All data of skin histopathology examination 
were analyzed by a statistical test according to the 
data type obtained. Mean values were compared using 
the Kruskal–Wallis test. If treatment had led to a 
marked difference, it would have continued with a fur-
ther statistical test to measure the differences between 
the groups. Post hoc analysis was performed using 
Mann–Whitney U-test. In this case, the significance 
level was set at 5%. As a result, which treatment gave 
the best result could be determined.
Results
In this research, evaluation was performed on the 
histopathologic preparations that had been made on 
microscopic images by scoring collagen, PMN, angio-
genesis, and fibrosis degree in each treatment group 
on days 8 and 15.
On day 8, there was a relatively similar micro-
scopic image in all treatment groups. The results of 
the evaluation showed the deposition of amorphous 
collagen was found in Group P0 and P1 (Figure-1a 
and b), while the deposition of disorganized collagen 
was found in Group P2, P3, and P4 (Figure-1c-e). 
The results also indicated that PMN cell count in 
all treatment groups was above 40. In addition, the 
degree of angiogenesis ranged from mild in Group P0 
(Figure-1a) to moderate one in Group P1, P2, P3, and 
P4 (Figure-1b-e). Fibrosis, on the other hand, was dom-
inated by mild degree, such as in Group P0, P1, P2, 
and P3 (Figure-2a-d), whereas Group P4 had moderate 
fibrosis (Figure-2e). Besides, the results of the statisti-
cal analysis demonstrated that there was no significant 
difference between Group P4 on day 8 and Groups P2 
and P3 on the same day (p> 0.05). However, there was 
a significant difference between Group P4 on day 8 and 
Groups P0 and P1 (p<0.05) on the same day (Table-1).
The results of the observation on day 15 showed a 
slightly different pattern. The collagen deposition found 
dominantly was in the disorganized form, such as in 
Group P1, P2, P3, and P4 (Figure-2b-e). Meanwhile, the 
amorphous one was only found in Group P0 (Figure-2a). 
The results also indicated that the PMN cell count in 
all treatment groups was still above 40 (Figure-2a-d), 
except in Group P4 (Figure-2e). Moreover, the degree 
of angiogenesis in all treatment groups was known to 
be dominated with mild degree. On the other hand, the 
fibrosis degree was dominated by severe ones such as 
in Group P0, P1, and P2 (Figure-2a-c). Meanwhile, the 
moderate fibrosis degree was only found in Group P1 
and P4 (Figure-2d and e).
Furthermore, the results of the statistical analysis 
revealed that Group P4 was not significantly different 
from Group P2 (p>0.05). However, there was a signif-
icant difference between Group P4 and Group P0, P1, 
as well as P3 (p>0.05) (Table-2).
Figure-1: Histopathological images of those albino 
rats’ skin on each treatment on day 8 (H and E, 100×, 
[a] P0, [b] P1, [c] P2, [d] P3, [e] P4). P0 - Amorphous 
collagen (arrow black), PMN >40 cells (green arrow), mild 
angiogenesis (orange arrow), and mild fibrosis degree 
(blue arrow). P1 - Amorphous collagen (arrow black), PMN 
>40 cells (green arrow), moderate angiogenesis (orange 
arrow), and mild fibrosis (blue arrow). P2 - Disorganized 
collagen (black arrow), PMN >40 cells (green arrow), 
moderate angiogenesis (orange arrow), and mild fibrosis 
(blue arrow). P3 - Disorganized collagen (black arrow), PMN 
>40 cells (green arrow), moderate angiogenesis (orange 
arrow), and mild fibrosis (blue arrow). P4 - Disorganized 
collagen (black arrow), PMN >40 cells (green arrow), 
moderate angiogenesis (orange arrow), and moderate 
fibrosis (blue arrow).
a b
c d
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The provision of 7.5% pomegranate extract 
standardized to 40% ellagic acid for 14 days gave 
the best result in accelerating the healing process of 
incised wound in those albino rats (Table-3).
Discussion
In this research, the efficacy of pomegranate 
extract ointment standardized to 40% ellagic acid for 
healing incised wounds in the albino rats was evalu-
ated. The results showed that the observation and treat-
ment periods can significantly influence the wound 
healing process characterized by collagen deposition, 
PMN, angiogenesis, and fibrosis degree. The results of 
the research indicated that 7.5% pomegranate extract 
ointment standardized to 40% ellagic acid could more 
effectively regulate the wound healing process if given 
14 days than Betadine ointment as well as 2.5% and 
5% pomegranate extract ointment standardized to 40% 
ellagic acid. Thus, in Group P4 the provision of the 
extract for 14 days was able to repair incised wounds 
with histopathologic features close to normal skin com-
position. The condition was characterized by well-orga-
nized and unorganized deposits, a PMN count of <40, 
light angiogenesis, as well as moderate fibrosis degree.
The results of the treatment scoring showed that 
Group P4 observed for 14 days got optimal result 
compared to the histopathology of normal skin since 
on day 14, proliferation and remodeling processes 
will continue for 21 days [24]. In this research, the 
administration of 7.5% pomegranate extract standard-
ized to 40% ellagic acid was also known to be able 
to regulate the healing process by increasing colla-
gen production, decreasing PMN cell infiltration, and 
increasing angiogenesis. The time required for the 
process is also shorter than the other treatment groups.
Pomegranates have been known to have various 
pharmacological activities, such as anti-inflammatory 
[25], antioxidant [26], antibacterial [27], antifungal 
[28], antispasmodic [29], antiulcer [30], and antican-
cer activities [31] as well as accelerate wound heal-
ing process [7]. A previous research even argues that 
pomegranates contain ellagic acid, tannins, and other 
compounds. Tannins and ellagic acids have antibac-
tesrial activity, thus accelerating the wound healing 
process. Unfortunately, its mechanism is still unclear. 
As a result, in this research the existence of these com-
pounds was expected can accelerate the healing pro-
cess of incised wound [13]. Pure ellagic acid (100%) 
has antioxidant, anti-inflammatory, and antibacterial 
activity. When the ellagic acid 40% of pomegranate 
extract was used in this study, it means that there are 
40% of ellagic acid and 60% of non-ellagic acid con-
tent. When the dosages used were equivalent to the 
most optimal dosage of pure ellagic acid (100%) are 
showed better results, then the strong suspicion that 
Table-1: Comparison of the wound healing process on day 8.
Treatment groups Deposition PMN Angiogenesis degree Fibrosis degree
P0 0.0a±0.00 0.0a±0.00 0.8a±0.45 0.8a±0.45
P1 0.2a±0.45 0.0a±0.00 2.0b±0.00 1.2ab±0.45
P2 1.0b±0.00 0.2ab±0.45 2.2b±0.45 1.8bc±0.45
P3 0.6ab±0.90 0.4ab±0.90 1.4ab±0.55 2.6c±0.55
P4 1.4b±0.55 0.8b±0.45 2.4b±0.55 2.4c±0.45
Score values were presented in the mean±SD. Different superscripts on the same polymer showed a significant 
difference (p<0.05). SD=Standard deviation, PMN=Polymorphonuclear neutrophils
Table-2: Comparison of the wound healing process on day 15.
Treatment groups Deposition PMN Angiogenesis degree Fibrosis degree
P0 0.6ab±0.55 0.0a±0.00 1.0a±0.00 3.0a±0.00
P1 1.0ab±0.00 0.2a±0.45 1.6ab±0.55 3.0a±0.00
P2 0.8ab±0.45 0.6ab±0.55 1.2ab±0.45 2.8a±0.45
P3 0.4a±0.55 0.2a±0.45 1.6ab±0.55 3.0a±0.00
P4 1.6b±0.55 1.4b±0.55 1.8b±0.45 2.6a±0.55
Score values were presented in the mean±SD. Different superscripts on the same polymer showed a significant 
difference (p<0.05). SD=Standard deviation, PMN=Polymorphonuclear neutrophils
Table-3: Comparison of the wound healing process on day 8 and 15.
Treatment groups Deposition PMN Angiogenesis degree Fibrosis degree
Day 8 Day 15 Day 8 Day 15 Day 8 Day 15 Day 8 Day 15
P0 0.0a±0.00 0.6a±0.55 0.0a±0.00 0.0a±0.00 0.8a±0.45 1.0a±0.00 0.8a±0.45 3.0b±0.00
P1 0.2a±0.45 1.0b±0.00 0.0a±0.00 0.2ab±0.45 2.0b±0.00 1.6ab±0.55 1.2c±0.45 3.0b±0.00
P2 1.0ab±0.00 0.8b±0.45 0.2a±0.45 0.6ab±0.55 2.2b±0.45 1.2a±0.45 1.8c±0.45 2.8b±0.45
P3 0.6ab±0.90 0.4a±0.55 0.4ab±0.90 0.2ab±0.45 1.4ab±0.55 1.6ab±0.55 2.6b±0.55 3.0b±0.00
P4 1.4ab±0.55 1.6b±0.55 0.8b±0.45 1.4b±0.55 2.4b±0.55 1.8b±0.45 2.4b±0.45 2.6bc±0.55
Score values were presented in the mean±SD. Different superscripts on the same polymer showed a significant 
difference (p<0.05). SD=Standard deviation, PMN=Polymorphonuclear neutrophils
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there is synergism of various materials that contained 
in pomegranate extract standardized 40%, so it also 
generates stronger effect [16].
In general, wound healing process can be divided 
into three different phases, namely, inflammatory phase, 
proliferation phase, and remodeling phase. Inflammation 
phase is characterized by the accumulation of inflam-
matory cells (PMN) in the wound area. The prolifera-
tive process, on the other hand, will be accompanied by 
epithelialization, angiogenesis, and collagen formation. 
Fibroblasts, collagen, edema, and new blood vessels 
then will soon form and get undergo maturation in the 
next remodeling phase. Collagen is indispensable for 
maintaining tissue strength in the wound area [32].
In other words, the provision of 7.5% pomegran-
ate extracts standardized to 40% ellagic acid could 
accelerate the healing process of the incised wound 
in those rats compared to other treatment groups since 
pomegranate has antioxidant, anti-inflammatory, and 
antibacterial activities. These three activities will be 
synergized in the process of wound healing.
Conclusion
The administration of 7.5% pomegranate extract 
standardized to 40% ellagic acid for 14 days on incised 
wounds of those albino rats can accelerate the wound 
healing process characterized by collagen deposition 
improvement, PMN infiltration in wound area, angio-
genesis, and fibrosis degree.
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